Profile cover photo
Profile photo
European Pharmaceutical Review
146 followers -
The leading bi-monthly technical journal for the pharmaceutical and life science industry
The leading bi-monthly technical journal for the pharmaceutical and life science industry

146 followers
About
European Pharmaceutical Review's posts

Post has attachment
Sustainable development indicators – can statistical indicators transform from back mirrors into drivers of change?
Johanna Laiho-Kauranne examines the 17 UN sustainable development goals that have been implemented for monitoring sustainability development...
http://buff.ly/2kQWC9e
Photo

Post has attachment
16 - 18 May 2017 Philadelphia, PA, USA
http://buff.ly/2legTsR
Photo

Post has attachment
Malaria control efforts can benefit from forecasting using satellites
Umeå University researcher Maquins Sewe has established links between patterns of malaria in Kenya and environmental factors (temperature, rainfall and land cover) measurable by satellite imagery. In his doctoral dissertation, the researcher shows that conducive environmental conditions occur before increases in hospital admissions and mortality due to malaria, indicating that the satellite information is useful…
http://buff.ly/2lnjFKJ
Photo

Post has attachment
Celltrion Healthcare's biosimilar shows positive results in Crohn’s disease study
Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar infliximab) in Crohn’s disease.
http://buff.ly/2lDlgi9
Photo

Post has attachment
Whitepaper: Accelerating development of enabled formulations for poorly soluble drugs
In this whitepaper, Quotient Clinical discuss poorly soluble drugs and how they have developed an innovative approach to identify and overcome these solubility challenges...
http://buff.ly/2lcMb3j
Photo

Post has attachment
Custom to build £20 million Pharmaceutical Innovation Centre in Brighton
Custom Pharma Services, the Brighton based CDMO, is pleased to announce the commencement of the building work on its £20 million Pharmaceutical Innovation Centre (PIC) in Moulsecoomb, Brighton. The Custom PIC will house the contract development, clinical and commercial manufacturing teams in a new, purpose built facility. This investment is in addition to the previously…
http://buff.ly/2l1zVT1
Photo

Post has attachment
FDA to review Mylan and Biocon’s biosimilar application
The US Food and Drug Administration (FDA) has accepted Mylan and Biocon's biologics license application for MYL-1401H, a proposed biosimilar to Neulasta...
http://buff.ly/2kFD7Al
Photo

Post has attachment
FDA approves new psoriasis drug that induced suicide in trial
The US Food and Drug Administration (FDA) has approved Valeant’s Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or injected) or phototherapy (ultraviolet light…
http://buff.ly/2kQxYGx
Photo

Post has attachment
A novel and intuitive operating concept revolutionizes Raman imaging
WITec presents a new operating concept with the powerful and intuitive Suite FIVE at Pittcon 2017...
http://buff.ly/2ktTDIy
Photo

Post has attachment
EC approves Eli Lilly’s rheumatoid arthritis drug
The European Commission has granted marketing authorisation for Eli Lilly and Incyte’s baricitinib (Olumiant) for the treatment of moderate to severe active rheumatoid arthritis (RA), in adult patients who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs). Baricitinib may be used as monotherapy or in combination with…
http://buff.ly/2lVJujO
Photo
Wait while more posts are being loaded